AbbVie Inc (ABBV)vsLifestance Health Group Inc (LFST)
ABBV
AbbVie Inc
$257.12
+0.83%
HEALTHCARE · Cap: $454.36B
LFST
Lifestance Health Group Inc
$12.97
-0.23%
HEALTHCARE · Cap: $4.82B
Smart Verdict
WallStSmart Research — data-driven comparison
AbbVie Inc generates 3963% more annual revenue ($64.39B vs $1.58B). ABBV leads profitability with a 9.8% profit margin vs 3.2%. ABBV trades at a lower P/E of 72.0x. ABBV earns a higher WallStSmart Score of 73/100 (B).
ABBV
Strong Buy73
out of 100
Grade: B
LFST
Hold48
out of 100
Grade: D+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-69.4%
Fair Value
$151.82
Current Price
$257.12
$105.30 premium
Margin of Safety
+36.0%
Fair Value
$10.83
Current Price
$12.97
$2.14 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Every $100 of equity generates 62 in profit
Strong operational efficiency at 40.0%
Earnings expanding 290.4% YoY
Conservative balance sheet, low leverage
Growing faster than its price suggests
Earnings expanding 1927.0% YoY
Conservative balance sheet, low leverage
Revenue surging 26.1% year-over-year
Areas to Watch
Premium valuation, high expectations priced in
Distress zone — elevated risk
Distress zone — elevated risk
ROE of 1.6% — below average capital efficiency
3.2% margin — thin
Premium valuation, high expectations priced in
Comparative Analysis Report
WallStSmart ResearchBull Case : ABBV
The strongest argument for ABBV centers on Market Cap, Return on Equity, Operating Margin. Revenue growth of 10.2% demonstrates continued momentum. PEG of 0.52 suggests the stock is reasonably priced for its growth.
Bull Case : LFST
The strongest argument for LFST centers on EPS Growth, Debt/Equity, Revenue Growth. Revenue growth of 26.1% demonstrates continued momentum.
Bear Case : ABBV
The primary concerns for ABBV are P/E Ratio, Altman Z-Score. A P/E of 72.0x leaves little room for execution misses.
Bear Case : LFST
The primary concerns for LFST are Altman Z-Score, Return on Equity, Profit Margin. A P/E of 97.1x leaves little room for execution misses. Thin 3.2% margins leave little buffer for downturns.
Key Dynamics to Monitor
ABBV profiles as a value stock while LFST is a growth play — different risk/reward profiles.
LFST carries more volatility with a beta of 1.22 — expect wider price swings.
LFST is growing revenue faster at 26.1% — sustainability is the question.
ABBV generates stronger free cash flow (3.2B), providing more financial flexibility.
Bottom Line
ABBV scores higher overall (73/100 vs 48/100) and 10.2% revenue growth. LFST offers better value entry with a 36.0% margin of safety. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
AbbVie Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories.
Lifestance Health Group Inc
HEALTHCARE · MEDICAL CARE FACILITIES · USA
LifeStance Health Group, Inc., provides outpatient mental health services to children, adolescents, adults and geriatrics. The company is headquartered in Scottsdale, Arizona.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?